MDLN
Get informed when a big investor buys or sells
+ FollowUndervalued by 20.7% based on the discounted cash flow analysis.
| Market cap | $33.22 Billion |
|---|---|
| Enterprise Value | $43.55 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.43 |
| Beta | -0.42 |
| Outstanding Shares | 819,000,000 |
| P/E Ratio | 32.46 |
|---|---|
| PEG | -53.94 |
| Price to Sales | 1.2 |
| Price to Book Ratio | 1.83 |
| Enterprise Value to Revenue | 1.49 |
| Enterprise Value to EBIT | 21.65 |
| Enterprise Value to Net Income | 45 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 1.12 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 38.79% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 3.99%▼ 74.42% |
|---|---|
| Total Invested | $1.29B▼ 95.45% |
| Investors Holding | 104▼ 224.00% |
No data
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medli...